Clinical trial

Predictors of Acute Exacerbation in Patients With COPD - an Observational Study

NCT04140097

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2020-02-26

PhaseN/A

Study timeline

Study start (actual)2020-02-26Date precision: day

Registry last updated2024-11-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseunresolved

COPDunresolved

COPD Exacerbationunresolved

COPD Exacerbation Acuteunresolved

Interventions

Prospective monitoring of a large variety of parametersOTHER

Sponsors & collaborators

Schön Klinik Berchtesgadener Landlead sponsor

GlaxoSmithKline GmbH & Co. KG (Munich, Germany)collaborator

Philipps University Marburgcollaborator

Research Office (Biostatistics), Paracelsus Medical University (Salzburg, Austria)collaborator

Fraunhofer ITEM, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (Hannover, Germany)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04140097 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.